End-of-day quote
Other stock markets
|
||
- USD | - |
|
05-21 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 | |
Gary Hogge
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-01-31 |
Ioana C. Hone
IRC | Investor Relations Contact | - | - |
George Samuel
LAW | General Counsel | 43 | 21-08-31 |
Derek Kelaita
PRN | Corporate Officer/Principal | - | 19-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Deborah Andrews
BRD | Director/Board Member | 66 | 14-04-10 |
Don Bailey
BRD | Director/Board Member | 78 | 20-02-29 |
Angus Russell
BRD | Director/Board Member | 68 | 14-12-08 |
Michael Mulroy
CHM | Chairman | 58 | 14-10-03 |
Director/Board Member | 67 | 21-05-03 | |
Dipti Amin
BRD | Director/Board Member | 60 | 21-04-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 188,823,975 | 188,001,177 ( 99.56 %) | 0 | 99.56 % |
Company contact information
Lineage Cell Therapeutics, Inc.
2173 Salk Avenue Suite 200
92008-7354, Carlsbad
+442 287 8990
http://www.lineagecell.com![address BioTime, Inc.](https://cdn.zonebourse.com/static/address/63947961.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+38.36% | 52.73B | |
+39.07% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- LCTX Stock
- Stock
- Company BioTime, Inc.